Last reviewed · How we verify
Evaluation of Energy Drinks on Electrocardiographic Parameters: A Randomized, Double Blind, Controlled, Crossover, Proof-of-concept Study
This is a clinical trial looking at the impact of energy drinks on heart related parameters. The study will enroll 3 participants who will be exposed to 8 different interventions.
Details
| Lead sponsor | University of the Pacific |
|---|---|
| Phase | Phase 4 |
| Status | RECRUITING |
| Enrolment | 3 |
| Start date | 2025-11-01 |
| Completion | 2026-09 |
Conditions
- Healthy Volunteers
- Safety After Oral Intake
Interventions
- Energy Drink A + Placebo Capsule
- Placebo Drink + Moxifloxacin Capsule
- Placebo Drink + Caffeine Capsule
- Placebo Drink + Placebo Capsule
- Energy Drink B
- Control Product + Taurine
- Control Product + Caffeine + Taurine
- Lower Dose Energy Drink A
Primary outcomes
- Change from Baseline in Corrected QT Interval (QTc) in Milliseconds (ms) — Baseline, 30, 60, 90, 120, 150, 180, and 240 minutes post-intervention
QTc interval will be calculated using both Bazett's and Fridericia's correction formulas assessed via 12-lead ECG.
Countries
United States